Browse
related articles
The listing is the latest in a substantial DIFX pipeline of equity issues by a wide range of companies.
Samih Darwazah, Chairman and Chief Executive of Hikma, said: "We are very pleased to announce the listing of our GDRs on the DIFX, in line with our stated intention at the time of our IPO. Through this listing we hope to reinforce our strong profile in our Middle East and North Africa (MENA) markets and to gain better access to the diverse Middle East investor base."
Henry Azzam, Chairman of the DIFX, said: "Hikma is the first pharmaceutical company to list securities on the DIFX. Its decision demonstrates the attraction of the exchange to companies in diverse sectors that are active across the DIFX region and beyond."
Nasser Alshaali, Chief Operations Officer of the DIFX, commented:
"The DIFX expects many more listings this year, including significant initial public offerings. Companies are contacting us in increasing numbers."
Posted by Anne-Birte Stensgaard, Senior News Editor
